Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

XTNT stock hub

Xtant Medical Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XTNTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

72.8M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

XTNT

In the news

Latest news · XTNT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E17.3

P25 14.9P50 23.2P75 38.5

ROE10.6

P25 -105.6P50 -46.5P75 -3.1

ROIC7.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XTNT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001453593
Company name	Xtant Medical Holdings, Inc.
Country	United States
Country code	US
Cusip	98420P308
Employees	151
Employees Change	-81%
Employees Change Percent	-34.91
Enterprise value	$84.5M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US98420P3082
Last refreshed	2026-05-10
Market cap	$72.8M
Market cap category	Micro-Cap
Price	$0.52
Price currency	USD
Rev Per Employee	886,933.77x
Sector	Healthcare
Sic	3841
Symbol	XTNT
Website	https://xtantmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.83%
EV Earnings	16.99x
EV Sales Forward	0.88x
EV/EBIT	11.6x
EV/EBITDA	6.76x
EV/FCF	8.31x
EV/Sales	0.63x
FCF yield	13.95%
P/B ratio	1.43x
P/E ratio	17.33x
P/S ratio	0.54x
PS Forward	0.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.44%
EBITDA Margin	9.34%
FCF margin	7.59%
Gross margin	62.92%
Gross Profit	$84.3M
Gross Profit Growth	23.54%
Gross Profit Growth Q	10.8%
Gross Profit Growth3 Y	37.9%
Gross Profit Growth5 Y	19.63%
Net Income	$5M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Pretax Margin	5.23%
Profit Margin	3.71%
Profit Per Employee	$32,934
Profitable Years	1
ROA	4.84
Roa5y	-4.63
ROCE	11.26
ROE	10.59
Roe5y	-14.04
ROIC	7.66
Roic5y	-12.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-31.87%
Cagr15y	-36.57%
Cagr1y	0.33%
Cagr3y	-5.95%
Cagr5y	-20.91%
EPS Growth Years	1
OCF Growth Q	709.02%
Revenue Growth	14.21x
Revenue Growth Q	2.68x
Revenue Growth Quarters	16x
Revenue Growth Years	5x
Revenue Growth3 Y	32.2x
Revenue Growth5 Y	20.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.42
Assets	$94.1M
Cash	$17.1M
Current Assets	$78.2M
Current Liabilities	$29.5M
Debt	$28.7M
Debt EBITDA	$2.1
Debt Equity	$0.56
Debt FCF	$2.83
Equity	$51M
Interest Coverage	1.98
Liabilities	$43.2M
Long Term Assets	$15.9M
Long Term Liabilities	$13.7M
Net Cash	$-11.7M
Net Cash By Market Cap	$-16.01
Net Debt EBITDA	$0.93
Net Debt Equity	$0.23
Net Debt FCF	$1.15
Tangible Book Value	$44.6M
Tangible Book Value Per Share	$0.32
WACC	5.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.65
Inventory Turnover	1.44
Net Working Capital	$46.7M
Quick ratio	1.18
Working Capital	$48.8M
Working Capital Turnover	$3.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.25%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-97.84%
1Y total return	0.33%
200-day SMA	0.64
3Y total return	-16.8%
50-day SMA	0.55
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.05%
All Time High	1,080
All Time High Change	-99.95%
All Time High Date	2011-01-03
All Time Low	0.33
All Time Low Change	57.1%
All Time Low Date	2024-12-16
ATR	0.03
Beta	-0.12
Beta1y	1.01
Beta2y	0.97
Ch YTD	-33.67
High	0.56
High52	0.95
High52 Date	2025-10-31
High52ch	-45.26%
Low	0.52
Low52	0.44
Low52 Date	2026-04-06
Low52ch	18.72%
Ma50ch	-5.61%
Premarket Change Percent	-2.89
Premarket Price	$0.55
Premarket Volume	252
Price vs 200-day SMA	-18.7%
RSI	45.72
RSI Monthly	44.49
RSI Weekly	40.99
Sharpe ratio	0.25x
Sortino ratio	0.5
Total Return	-12.25%
Tr YTD	-33.67
Tr15y	-99.89%
Tr1m	14.04%
Tr1w	-5.36%
Tr3m	-12.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.02
Earnings Revenue Estimate	19,785,000x
Earnings Revenue Estimate Growth	-39.87x
Operating Income	$7.3M
Operating margin	5.44
Price target	$1
Price Target Change	$92.31

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,099,310%
Float Percent	38.62%
Net Borrowing	-9,330,000
Shares Insiders	12.55%
Shares Institutions	14.31%
Shares Out	140,068,260
Shares Qo Q	0.06%
Shares Yo Y	12.25%
Short Float	0.02%
Short Ratio	0.07
Short Shares	0.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$7.3M
Average Volume	134,011.8x
Bv Per Share	0.36
CAPEX	$-2.4M
Ch10y	-97.84
Ch15y	-99.89
Ch1m	14.04
Ch1w	-5.37
Ch1y	0.33
Ch3m	-12.06
Ch3y	-16.8
Ch5y	-69.05
Ch6m	-30.91
Change	-8.77%
Change From Open	-5.47
Close	0.57
Days Gap	-3.49
Depreciation Amortization	5,223,000
Dollar Volume	148,398.6
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$7.3M
EBITDA	$12.5M
EPS	$0.03
F Score	8
FCF	$10.2M
FCF EV Yield	12.03x
FCF Per Share	$0.07
Financing CF	-9,570,000
Fiscal Year End	December
Goodwill	6,074,000
Graham Number	0.49558
Graham Upside	-4.7
Income Tax	$2M
Investing CF	7,899,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2018-02-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	0.64
Ma150ch	-19.29%
Ma20	0.53
Ma20ch	-1.23%
Net CF	11,107,000
Next Earnings Date	2026-05-13
Open	0.55
Optionable	No
P FCF Ratio	7.17
P OCF Ratio	5.81
Position In Range	0
Ppne	9,394,000
Pre Close	0.57
Price Date	2026-05-08
Price EBITDA	$5.82
Ptbv Ratio	1.63
Relative Volume	2.13x
Revenue	133,927,000x
SBC By Revenue	2.16x
Share Based Comp	2,892,000
Tax By Revenue	1.51x
Tax Rate	28.97%
Tr6m	-30.91%
Us State	Montana
Volume	285,382
Z Score	-0.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XTNT pay a dividend?

Capital-return profile for this ticker.

Performance

XTNT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XTNT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.3%

Float: +38.6% of shares outstanding

Insider ownership

+12.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

XTNT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.7

Neutral momentum band

Price vs 200-day MA

-18.7%

50/200-day relationship not available

Beta (5Y)

-0.12

Less volatile than the market

Sharpe ratio

0.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XTNT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current XTNT stock rating?

Xtant Medical Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full XTNT analysis?

The full report lives at /stocks/XTNT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for XTNT?

The latest report frames XTNT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the XTNT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.